Reviewing The Case For Kohl’s Corp. (KSS) Going Higher

BlackRock Fund Advisors recently announced the acquisition of new stake in Kohl’s Corp. (NYSE:KSS). The institutional investor has increased its shareholding in the Consumer Cyclical company by 0.30% to 11.8 million shares with purchase of 35689.0 shares. This fresh investment now brings its stake to 10.66% valued currently at $338.46 million. In addition, Macellum Advisors LP raised its holdings by 5329.0 to 5.47 million shares. And Dimensional Fund Advisors LP has lifted its position by 6.81% or 0.35 million shares – to 5.43 million shares.

Currently, there are 111.00M common shares owned by the public and among those 108.65M shares have been available to trade.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Insiders at the company have transacted a total of 105 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 75 of these insider trades were purchases, accounting for 855,953 shares. Insider sales of the common stock occurred on 30 occasions, with total insider shares sold totaling 116,358 shares.

The top 3 mutual fund holders in Kohl’s Corp. are iShares Core S&P Small Cap ETF, Vanguard Total Stock Market ETF, and T Rowe Price Equity Income Fund. iShares Core S&P Small Cap ETF owns 7.41 million shares of the company’s stock, all valued at over $212.45 million. The company sold 26762.0 shares recently to bring their total holdings to about 6.69% of the shares outstanding. Vanguard Total Stock Market ETF bought 0.22 million shares to see its total holdings expand to 3.56 million shares valued at over $101.97 million and representing 3.21% of the shares outstanding. T Rowe Price Equity Income Fund sold 65000.0 shares to bring its total holdings to over 2.85 million shares at a value of $81.88 million. T Rowe Price Equity Income Fund now owns shares totaling to 2.58% of the shares outstanding.

The company’s stock has a 5-day price change of 7.71% and 25.65% over the past three months. KSS shares are trading -2.13% year to date (YTD), with the 12-month market performance down to -12.25% lower. It has a 12-month low price of $17.68 and touched a high of $35.77 over the same period. KSS has an average intraday trading volume of 5.76 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.75%, 8.08%, and 18.31% respectively.

Institutional ownership of Kohl’s Corp. (NYSE: KSS) shares accounts for 108.79% of the company’s 111.00M shares outstanding. Mutual fund holders own 59.65%, while other institutional holders and individual stakeholders account for 6.19% and 50.75% respectively.

It has a market capitalization of $3.11B and a beta (3y monthly) value of 2.00. The earnings-per-share (ttm) stands at -$1.30. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.57% over the week and 4.58% over the month.

Analysts forecast that Kohl’s Corp. (KSS) will achieve an EPS of $1.25 for the current quarter, $0.07 for the next quarter and $2.62 for 2025. The lowest estimate earnings-per-share for the quarter is $0.78 while analysts give the company a high EPS estimate of $1.69. Comparatively, EPS for the current quarter was -$2.49 a year ago. Earnings per share for the fiscal year are expected to increase by 1737.10%, and 8.62% over the next financial year.

Looking at the support for the KSS, a number of firms have released research notes about the stock. Telsey Advisory Group stated their Market Perform rating for the stock in a research note on November 22, 2023, with the firm’s price target at $29-$25.

Most Popular

Related Posts